NASDAQ
No price data available for this timeframe.
Odonate Therapeutics, Inc., a pharmaceutical company established in 2013 and headquartered in New York, New York, is dedicated to creating treatments for cancer. Its primary therapeutic in development is tesetaxel, an orally administered chemotherapy drug. This agent is currently undergoing a Phase III clinical study for its application in patients suffering from metastatic breast cancer.
Open
$22005.00
Previous Close
$17000.00
Day High
$22005.00
Day Low
$22005.00
52 Week High
$358000.00
52 Week Low
$22005.00